The New York Genome Center (NYGC) is an independent, nonprofit academic research institution that serves as a multi-institutional hub for genomic research. Leveraging our strengths in whole-genome sequencing and genomic analysis, our mission is the advancement of genomic science and its application to drive novel biomedical discoveries. NYGC’s areas of focus include the development of computational and experimental genomic methods and disease-focused research to better understand the genetic basis of cancer, neurodegenerative disease, and neuropsychiatric disease. In 2020, the NYGC also has directed its expertise to COVID-19 research.

We are committed to prioritizing diversity, equity, and inclusion, which is fundamental to promoting greater collaboration, innovation, and discovery. Learn more about NYGC’s Commitment to Diversity, Equity, and Inclusion.

Human Genomics. 2021 July 13.

Coding and noncoding variants in EBF3 are involved in HADDS and simplex autism.

Evin M Padhi, Tristan J Hayeck, Zhang Cheng, Sumantra Chatterjee, Brandon J Mannion, Marta Byrska-Bishop, Marjolaine Willems, Lucile Pinson, Sylvia Redon, Caroline Benech, Kevin Uguen, Séverine Audebert-Bellanger, Cédric Le Marechal, Claude Férec, Stephanie Efthymiou, Fatima Rahman, Shazia Maqbool, Reza Maroofian, Henry Houlden, Rajeeva Musunuri, Giuseppe Narzisi, Avinash Abhyankar, Riana D Hunter, Jennifer Akiyama, Lauren E Fries, Jeffrey K Ng, Elvisa Mehinovic, Nick Stong, Andrew S Allen, Diane E Dickel, Raphael A Bernier, David U Gorkin, Len A Pennacchio, Michael C Zody, Tychele N Turner

Institutional Founding Members

Institutional Associate Members